Trial Profile
A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants With Chronic Kidney Disease
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Apr 2024
Price :
$35
*
At a glance
- Drugs Roxadustat (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 12 Dec 2023 Status changed from not yet recruiting to recruiting.
- 02 Aug 2023 New trial record